288 related articles for article (PubMed ID: 9520463)
1. The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis.
Yamada Y; Warren AJ; Dobson C; Forster A; Pannell R; Rabbitts TH
Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3890-5. PubMed ID: 9520463
[TBL] [Abstract][Full Text] [Related]
2. The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice.
Yamada Y; Pannell R; Forster A; Rabbitts TH
Proc Natl Acad Sci U S A; 2000 Jan; 97(1):320-4. PubMed ID: 10618416
[TBL] [Abstract][Full Text] [Related]
3. A DNA-binding mutant of TAL1 cooperates with LMO2 to cause T cell leukemia in mice.
Draheim KM; Hermance N; Yang Y; Arous E; Calvo J; Kelliher MA
Oncogene; 2011 Mar; 30(10):1252-60. PubMed ID: 21057528
[TBL] [Abstract][Full Text] [Related]
4. Structure of the leukemia oncogene LMO2: implications for the assembly of a hematopoietic transcription factor complex.
El Omari K; Hoosdally SJ; Tuladhar K; Karia D; Vyas P; Patient R; Porcher C; Mancini EJ
Blood; 2011 Feb; 117(7):2146-56. PubMed ID: 21076045
[TBL] [Abstract][Full Text] [Related]
5. The transcription factors Scl and Lmo2 act together during development of the hemangioblast in zebrafish.
Patterson LJ; Gering M; Eckfeldt CE; Green AR; Verfaillie CM; Ekker SC; Patient R
Blood; 2007 Mar; 109(6):2389-98. PubMed ID: 17090656
[TBL] [Abstract][Full Text] [Related]
6. Expression of the leukemia oncogene Lmo2 is controlled by an array of tissue-specific elements dispersed over 100 kb and bound by Tal1/Lmo2, Ets, and Gata factors.
Landry JR; Bonadies N; Kinston S; Knezevic K; Wilson NK; Oram SH; Janes M; Piltz S; Hammett M; Carter J; Hamilton T; Donaldson IJ; Lacaud G; Frampton J; Follows G; Kouskoff V; Göttgens B
Blood; 2009 Jun; 113(23):5783-92. PubMed ID: 19171877
[TBL] [Abstract][Full Text] [Related]
7. Chromosomal translocations and leukaemia: a role for LMO2 in T cell acute leukaemia, in transcription and in erythropoiesis.
Rabbitts TH; Axelson H; Forster A; Grutz G; Lavenir I; Larson R; Osada H; Valge-Archer V; Wadman I; Warren A
Leukemia; 1997 Apr; 11 Suppl 3():271-2. PubMed ID: 9209362
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional control of fetal liver hematopoiesis: dominant negative effect of the overexpression of the LIM domain mutants of LMO2.
Terano T; Zhong Y; Toyokuni S; Hiai H; Yamada Y
Exp Hematol; 2005 Jun; 33(6):641-51. PubMed ID: 15911088
[TBL] [Abstract][Full Text] [Related]
9. Identification of DeltaEF1 as a novel target that is negatively regulated by LMO2 in T-cell leukemia.
Sun W; Yang S; Shen W; Li H; Gao Y; Zhu TH
Eur J Haematol; 2010 Dec; 85(6):508-19. PubMed ID: 20731704
[TBL] [Abstract][Full Text] [Related]
10. LMO2 Oncoprotein Stability in T-Cell Leukemia Requires Direct LDB1 Binding.
Layer JH; Alford CE; McDonald WH; Davé UP
Mol Cell Biol; 2016 Feb; 36(3):488-506. PubMed ID: 26598604
[TBL] [Abstract][Full Text] [Related]
11. Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1.
Gering M; Yamada Y; Rabbitts TH; Patient RK
Development; 2003 Dec; 130(25):6187-99. PubMed ID: 14602685
[TBL] [Abstract][Full Text] [Related]
12. The role of LMO2 in development and in T cell leukemia after chromosomal translocation or retroviral insertion.
Nam CH; Rabbitts TH
Mol Ther; 2006 Jan; 13(1):15-25. PubMed ID: 16260184
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic-specific genes are not induced during in vitro differentiation of scl-null embryonic stem cells.
Elefanty AG; Robb L; Birner R; Begley CG
Blood; 1997 Aug; 90(4):1435-47. PubMed ID: 9269761
[TBL] [Abstract][Full Text] [Related]
14. The LMO2 T-cell oncogene is activated via chromosomal translocations or retroviral insertion during gene therapy but has no mandatory role in normal T-cell development.
McCormack MP; Forster A; Drynan L; Pannell R; Rabbitts TH
Mol Cell Biol; 2003 Dec; 23(24):9003-13. PubMed ID: 14645513
[TBL] [Abstract][Full Text] [Related]
15. The LIM-domain binding protein Ldb1 and its partner LMO2 act as negative regulators of erythroid differentiation.
Visvader JE; Mao X; Fujiwara Y; Hahm K; Orkin SH
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13707-12. PubMed ID: 9391090
[TBL] [Abstract][Full Text] [Related]
16. LIM-only protein Lmo2 forms a protein complex with erythroid transcription factor GATA-1.
Osada H; Grutz GG; Axelson H; Forster A; Rabbitts TH
Leukemia; 1997 Apr; 11 Suppl 3():307-12. PubMed ID: 9209374
[TBL] [Abstract][Full Text] [Related]
17. Protein stability and transcription factor complex assembly determined by the SCL-LMO2 interaction.
Lécuyer E; Larivière S; Sincennes MC; Haman A; Lahlil R; Todorova M; Tremblay M; Wilkes BC; Hoang T
J Biol Chem; 2007 Nov; 282(46):33649-33658. PubMed ID: 17878155
[TBL] [Abstract][Full Text] [Related]
18. The LIM domain protein Lmo2 binds to AF6, a translocation partner of the MLL oncogene.
Bégay-Müller V; Ansieau S; Leutz A
FEBS Lett; 2002 Jun; 521(1-3):36-8. PubMed ID: 12067721
[TBL] [Abstract][Full Text] [Related]
19. Homo-binding character of LMO2 isoforms and their both synergic and antagonistic functions in regulating hematopoietic-related target genes.
Sun W; Shen WW; Yang S; Hu F; Gao Y; Qiao YH; Zhu TH
J Biomed Sci; 2010 Mar; 17(1):22. PubMed ID: 20346173
[TBL] [Abstract][Full Text] [Related]
20. An antibody inhibitor of the LMO2-protein complex blocks its normal and tumorigenic functions.
Nam CH; Lobato MN; Appert A; Drynan LF; Tanaka T; Rabbitts TH
Oncogene; 2008 Aug; 27(36):4962-8. PubMed ID: 18438427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
